Milestone Collaboration! Hemos Bio × Leng Suan Ling: Launching a New Pathway for Anti-Sensitivity and Repair

Recently, Hemos Bioscience officially established a strategic partnership with Dengkang Oral Care, a leading company in the oral care industry, and has, for the first time, become part of Dencare‌'s supply chain system. This marks a significant milestone breakthrough, as  Hemos Bioscience’s raw materials have successfully entered the supply chains of China’s top oral care companies.

In late August, under the Dencare‌ brand Nationwide professional anti-allergy brand, Leng Suan Ling. Introducing the brand-new Medical Research Anti-Allergy Series— Recombinant Protein-Based Repair Toothpaste This product innovatively combines Hemos' patented bioactive ingredient, recombinant keratin, with Coldrex's patented bioactive glass (ceramic) to create the groundbreaking "OPTIGUARD oral tissue biomimetic technology." Achieves dual-action gum and tooth repair functionality. 。

The product underwent two years of rigorous R&D, encompassing the entire process—from formulation development and efficacy verification to clinical trials and finally, market launch—with meticulous quality control at every stage. To validate the product’s actual efficacy, a clinical efficacy trial involving over 100 participants was conducted, with subjects using the product continuously for eight weeks. The results showed that the toothpaste containing recombinant keratin can significantly repair damaged oral tissues caused by sensitivity, thereby confirming its clinical effectiveness.

After the product was launched, it received an enthusiastic market response and quickly climbed to the top of the new sensitive-toothpaste rankings, remaining at the No. 1 spot for four consecutive days—evidence of consumers’ strong endorsement of its innovative protein-repair technology.

Leveraging its technological prowess and R&D strengths in the field of recombinant proteins,  Hemos Bioscience has successfully gained recognition from Leng Suan Ling, a leading domestic oral care brand. Currently,  Hemos Bioscience is continuously expanding its collaborations in the oral care sector while also developing a diversified business portfolio spanning medical care, medical aesthetics, and consumer products, further solidifying its leading position in the functional biomaterials market.

In the future, Hemos Bioscience will remain committed to a market-oriented approach centered on customer needs, continuously focusing on safe, efficient, and innovative recombinant keratin biomaterial solutions. By providing core raw materials, we will empower brand owners to enhance their product competitiveness and help our partners achieve value upgrades.